Thor A Wagner, MD
Specialties
- Academic Title: Assistant Professor
- On Staff Since: July 2008
"My research is inspired by patients that I meet and directed at the problems that they face. There are exciting opportunities to adapt current biotechnology to help our patients' needs, and it's great motivation to know that the research we do has the potential to directly benefit our patients."
-
Biography
Thor Wagner, MD: Assistant Professor of Pediatric Infectious Diseases. Dr. Wagner's research is focused on pediatric HIV infection, which accounts for 15% of all HIV deaths.
My primary interest is understanding chronic HIV infection during antiretroviral therapy. Specifically, why doesn't antiretroviral therapy eradicate HIV infection? Is there ongoing viral replication? Is there proliferation of cells with viable proviral HIV? Can we identify the remaining infected cells? Is immune tolerance to HIV a barrier to curing HIV? Answers to these questions should help design new treatment strategies more likely to cure HIV.
My other research interest is improving infectious disease diagnostics in low resource settings. Specifically, I am working to develop a point-of-care diagnostic test for infant HIV. Currently there is no simple test to diagnose infants with HIV, and 50% of HIV-infected children die before they can be diagnosed. To accomplish this we are utilizing state-of-the-art monoclonal antibody screening technology to optimize the sensitivity of immunoassays to detect HIV antigens.- Board Certification(s)
-
Pediatric Infectious Diseases
Pediatrics
- Education
-
Temple University School of Medicine, Philadelphia, PA
- Residency
-
Children's Hospital of New York, New York, NY
- Fellowship
-
Seattle Children's Hospital, Seattle, WA
- Clinical Interests
-
General pediatric infectious diseases, pediatric HIV
Mechanism of persistent HIV infection despite effective treatment, improving HIV diagnostics for the low resource settings - Research Description
-
My research is focused on pediatric HIV infection, which accounts for 15percent of all HIV deaths.
My primary interest is understanding chronic HIV infection during antiretroviral therapy. Specifically, why doesn't antiretroviral therapy eradicate HIV infection? Is there ongoing viral replication? Is there proliferation of cells with viable proviral HIV? Can we identify the remaining infected cells? Is immune tolerance to HIV a barrier to curing HIV? Answers to these questions should help design new treatment strategies more likely to cure HIV.
My other research interest is improving infectious disease diagnostics in low resource settings. Specifically, I am working to develop a point-of-care diagnostic test for infant HIV. Currently there is no simple test to diagnose infants with HIV, and 50percent of HIV-infected children die before they can be diagnosed. To accomplish this we are utilizing state-of-the-art monoclonal antibody screening technology to optimize the sensitivity of immunoassays to detect HIV antigens. - Research Focus Area
-
Infectious Disease
-
Related Resources
-
Patient Testimonials
Loading...-
{{ testimonial.testimony }}
-
-
Awards and Honors
Loading...Award Name Award Description Awarded By Award Date {{ award.name }} {{ award.description }} {{ award.organization }} {{ award.displayDate }} No Awards and Honors found for Thor A Wagner, MD
-
Publications
Loading...Manuscripts in Refereed Journals
Book Chapters
Published Books, Videos, Software, etc.
Manuscripts Submitted
Published Abstracts
Other Publications
No Publications found for Thor A Wagner, MD
-
Presentations
Loading...Presentation Title Event Location Date {{ presentation.title }} {{ presentation.presentedAt }} {{ presentation.location }} {{ presentation.displayDate }} No Presentations found for Thor A Wagner, MD
-
Research Funding
Loading...Grant Title Grantor Amount Award Date {{ funding.title }} {{ funding.grantedBy }} {{ funding.amount }} {{ funding.displayDate }} No Research Funding found for Thor A Wagner, MD
-
Clinical Trials and Research
Loading...{{ item.st }}
No clinical trials found for Thor A Wagner, MD.